{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:57:16Z","timestamp":1791986236965,"version":"4.4.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.genhosppsych.2004.11.004","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T18:34:53Z","timestamp":1110566093000},"page":"140-144","source":"Crossref","is-referenced-by-count":56,"title":["Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study"],"prefix":"10.1016","volume":"27","author":[{"given":"Horacio","family":"Preval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Southard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2004.11.004_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00023210-200216040-00002","article-title":"Pharmacological treatment of psychotic agitation","volume":"16","author":"Currier","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4088\/JCP.v61n1208","article-title":"Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis","volume":"61","author":"Brook","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002130000658","article-title":"Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial","volume":"155","author":"Daniel","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v62n0104","article-title":"Intramuscular ziprasidone 2 mg versus 10 mg, in the short-term management of agitated psychotic patients","volume":"62","author":"Lesem","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib5","doi-asserted-by":"crossref","unstructured":"Brook S, Walden J, Benattia I, Siu CO, Romano SJ. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: Comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology [in press].","DOI":"10.1007\/s00213-004-2082-5"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4088\/JCP.v64n0502","article-title":"A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients","volume":"64","author":"Shale","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3956(01)00052-8","article-title":"Validation of the behavioral activity rating scale (BARS\u2122): a novel measure of activity in agitated patients","volume":"36","author":"Swift","year":"2002","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose\u2013response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia","volume":"6","author":"Kasper","year":"2003","journal-title":"Int. J. Neuropsychopharmacol. (England)"},{"key":"10.1016\/j.genhosppsych.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"J. Clin. Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T15:38:00Z","timestamp":1549208280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834304001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0163834304001409"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2004.11.004","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}